Literature DB >> 28550076

High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS.

Maria Blomqvist1, Jan Borén2, Henrik Zetterberg3, Kaj Blennow4, Jan-Eric Månsson1, Marcus Ståhlman5.   

Abstract

Sulfatides (STs) are a group of glycosphingolipids that are highly expressed in brain. Due to their importance for normal brain function and their potential involvement in neurological diseases, development of accurate and sensitive methods for their determination is needed. Here we describe a high-throughput oriented and quantitative method for the determination of STs in cerebrospinal fluid (CSF). The STs were extracted using a fully automated liquid/liquid extraction method and quantified using ultra-performance liquid chromatography coupled to tandem mass spectrometry. With the high sensitivity of the developed method, quantification of 20 ST species from only 100 μl of CSF was performed. Validation of the method showed that the STs were extracted with high recovery (90%) and could be determined with low inter- and intra-day variation. Our method was applied to a patient cohort of subjects with an Alzheimer's disease biomarker profile. Although the total ST levels were unaltered compared with an age-matched control group, we show that the ratio of hydroxylated/nonhydroxylated STs was increased in the patient cohort. In conclusion, we believe that the fast, sensitive, and accurate method described in this study is a powerful new tool for the determination of STs in clinical as well as preclinical settings.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Alzheimer’s disease; sulfatides; ultra-performance liquid chromatography-tandem mass spectrometry

Mesh:

Substances:

Year:  2017        PMID: 28550076      PMCID: PMC5496026          DOI: 10.1194/jlr.D076588

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  46 in total

1.  Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia.

Authors:  P Fredman; A Wallin; K Blennow; P Davidsson; C G Gottfries; L Svennerholm
Journal:  Acta Neurol Scand       Date:  1992-02       Impact factor: 3.209

2.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

Review 3.  Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders.

Authors:  P Fredman; A Lekman
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

4.  Selective desorption/ionization of sulfatides by MALDI-MS facilitated using 9-aminoacridine as matrix.

Authors:  Hua Cheng; Gang Sun; Kui Yang; Richard W Gross; Xianlin Han
Journal:  J Lipid Res       Date:  2010-02-01       Impact factor: 5.922

5.  Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration.

Authors:  Inge Zöller; Marion Meixner; Dieter Hartmann; Heinrich Büssow; Rainer Meyer; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

Review 6.  The enigmatic role of sulfatides: new insights into cellular functions and mechanisms of protein recognition.

Authors:  Shuyan Xiao; Carla V Finkielstein; Daniel G S Capelluto
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Changes in the fatty acid composition of cerebrosides and sulfatides of human nervous tissue with age.

Authors:  L Svennerholm; S Ställberg-Stenhagen
Journal:  J Lipid Res       Date:  1968-03       Impact factor: 5.922

Review 8.  The role and metabolism of sulfatide in the nervous system.

Authors:  Matthias Eckhardt
Journal:  Mol Neurobiol       Date:  2008-05-09       Impact factor: 5.590

9.  Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy.

Authors:  Christine Í Dali; Norman W Barton; Mohamed H Farah; Mihai Moldovan; Jan-Eric Månsson; Nitin Nair; Morten Dunø; Lotte Risom; Hongmei Cao; Luying Pan; Marcia Sellos-Moura; Andrea M Corse; Christian Krarup
Journal:  Ann Clin Transl Neurol       Date:  2015-03-27       Impact factor: 4.511

10.  The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid.

Authors:  Michael G Harrington; Alfred N Fonteh; Elena Oborina; Patricia Liao; Robert P Cowan; Gordon McComb; Jesus N Chavez; John Rush; Roger G Biringer; Andreas F Hühmer
Journal:  Cerebrospinal Fluid Res       Date:  2009-09-07
View more
  5 in total

Review 1.  The role of sphingolipids in psychoactive drug use and addiction.

Authors:  Liubov S Kalinichenko; Erich Gulbins; Johannes Kornhuber; Christian P Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-01-10       Impact factor: 3.575

2.  T cells from MS Patients with High Disease Severity Are Insensitive to an Immune-Suppressive Effect of Sulfatide.

Authors:  Mio Hamatani; Hirofumi Ochi; Kimitoshi Kimura; Shinji Ashida; Yuichiro Hashi; Yoichiro Okada; Chihiro Fujii; Kazuyuki Kawamura; Toshiki Mizuno; Hideki Ueno; Ryosuke Takahashi; Takayuki Kondo
Journal:  Mol Neurobiol       Date:  2022-06-11       Impact factor: 5.682

Review 3.  Sphingolipids as Regulators of Neuro-Inflammation and NADPH Oxidase 2.

Authors:  Emma J Arsenault; Colin M McGill; Brian M Barth
Journal:  Neuromolecular Med       Date:  2021-02-05       Impact factor: 4.103

4.  Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy.

Authors:  Giacomo Frati; Marco Luciani; Vasco Meneghini; Silvia De Cicco; Marcus Ståhlman; Maria Blomqvist; Serena Grossi; Mirella Filocamo; Francesco Morena; Andrea Menegon; Sabata Martino; Angela Gritti
Journal:  Cell Death Dis       Date:  2018-06-13       Impact factor: 8.469

5.  Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain-Barré syndrome.

Authors:  Mária Péter; Wanda Török; Anna Petrovics-Balog; László Vígh; László Vécsei; Gábor Balogh
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.